Cargando…

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease

BACKGROUND & AIMS: Crohn’s disease (CD) is a lifelong illness with substantial morbidity, although new therapies and treatment paradigms have been developed. We provide guidance for treatment of ambulatory patients with mild to severe active luminal CD. METHODS: We performed a systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panaccione, Remo, Steinhart, A Hillary, Bressler, Brian, Khanna, Reena, Marshall, John K, Targownik, Laura, Afif, Waqqas, Bitton, Alain, Borgaonkar, Mark, Chauhan, Usha, Halloran, Brendan, Jones, Jennifer, Kennedy, Erin, Leontiadis, Grigorios I, Loftus, Edward V, Meddings, Jonathan, Moayyedi, Paul, Murthy, Sanjay, Plamondon, Sophie, Rosenfeld, Greg, Schwartz, David, Seow, Cynthia H, Williams, Chadwick, Bernstein, Charles N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Clinical Practice Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619415/ https://www.ncbi.nlm.nih.gov/pubmed/31294378 http://dx.doi.org/10.1093/jcag/gwz019

Ejemplares similares

COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities, as of March 16, 2020
por: Tse, Frances, et al.
Publicado: (2020)

Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-n-butylbromide (Buscopan) During Gastrointestinal Endoscopy
por: Forbes, Nauzer, et al.
Publicado: (2021)

Do You See What I See? An Assessment of Endoscopic Lesions Recognition and Description by Gastroenterology Trainees and Staff Physicians
por: Hart, Lara, et al.
Publicado: (2020)

Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2019)

Canadian Association of Gastroenterology Statement on the Putative Link Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter pylori Eradication
por: Leontiadis, Grigorios I, et al.
Publicado: (2018)

COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology
por: Tse, Frances, et al.
Publicado: (2021)

Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn’s Disease With a Loss of Response
por: Heron, Valerie, et al.
Publicado: (2022)

American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period
por: Abraham, Neena S., et al.
Publicado: (2022)

Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease
por: Mack, David R, et al.
Publicado: (2019)

Cost-Effectiveness of Tight Control for Crohn’s Disease With Adalimumab-Based Treatment: Economic Evaluation of the CALM Trial From a Canadian Perspective
por: Lakatos, Peter L, et al.
Publicado: (2022)

Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea
por: Sadowski, Daniel C, et al.
Publicado: (2019)

Ustekinumab Therapeutic Drug Monitoring—Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial
por: Afif, Waqqas, et al.
Publicado: (2021)

Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2020)

Providing Hospitalized Ulcerative Colitis Patients With Practice Guidelines Improves Patient-Reported Outcomes
por: Weizman, Adam V, et al.
Publicado: (2020)

Luminal and Extraluminal Applications of Endoscopic Stenting: A Bright Future for Gastroenterology
por: Ferreira-Silva, Joel, et al.
Publicado: (2023)

COVID-19: Framework for the Resumption of Endoscopic Activities From the Canadian Association of Gastroenterology
por: Ménard, Charles, et al.
Publicado: (2020)

Re-cherchez la Femme: A Second Look at Women in Gastroenterology in Canada
por: Gupta, Milli, et al.
Publicado: (2020)

Canadian Association of Gastroenterology Indicators of Safety Compromise following Colonoscopy in Clinical Practice
por: Borgaonkar, Mark R., et al.
Publicado: (2016)

Medical Summary Template for the Transfer of Patients with Inflammatory Bowel Disease from Pediatric to Adult Care
por: Benchimol, Eric I, et al.
Publicado: (2021)

Thiopurines in the Management of Crohn's Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity—A Retrospective Study
por: Benmassaoud, Amine, et al.
Publicado: (2016)

Patients’ Experiences and Priorities for Accessing Gastroenterology Care
por: Telford, Jennifer J, et al.
Publicado: (2019)

Recent advances on the management of patients with non-variceal upper gastrointestinal bleeding
por: Sheasgreen, Christopher, et al.
Publicado: (2013)

Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease
por: Restellini, Sophie, et al.
Publicado: (2021)

A12 EXAMINING THE ASSOCIATIONS BETWEEN PHYSICIAN OR PATIENT GENDER WITH REFERRAL PATTERNS IN GASTROENTEROLOGY FOR NON-SCREENING INDICATIONS
por: Wang, G, et al.
Publicado: (2023)

Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease
por: Chao, Che-Yung, et al.
Publicado: (2019)

Something Is Missing: Addressing Racial Diversity, Equity, Inclusion and Representation in Canadian Gastroenterology
por: Williams, Chadwick I
Publicado: (2021)

Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects
por: Turpin, Williams, et al.
Publicado: (2020)

Surgical Rates for Crohn’s Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study
por: Ma, Christopher, et al.
Publicado: (2017)

Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF Exposure
por: Bressler, Brian, et al.
Publicado: (2018)

GASTROENTEROLOGY
Publicado: (1982)

GASTROENTEROLOGY
Publicado: (1972)

Gastroenterology
Publicado: (2011)

Gastroenterology
por: Davies, E. Rhys
Publicado: (1992)

Gastroenterology
por: Chopra, Angeli
Publicado: (2015)

The Argument Against a Biosimilar Switch Policy for Infliximab in Patients with Inflammatory Bowel Disease Living in Alberta
por: Kaplan, Gilaad G, et al.
Publicado: (2020)

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS)
por: Moayyedi, Paul, et al.
Publicado: (2019)

Cost of Refractory Crohn’s Disease Before and After Ustekinumab Utilization
por: Rahme, Elham, et al.
Publicado: (2019)

A158 COMPARING CORTIMENT® AND PREDNISONE IN ULCERTATIVE COLITIS: A POPULATION-BASED STUDY OF OUTCOMES
por: Coward, S, et al.
Publicado: (2022)

The Great Debate With IBD Biosimilars: Con: Biosimilars Should Not Be Routinely Used as a First Line Biologic and Not Switched From Reference Biologics
por: Panaccione, Remo
Publicado: (2021)

Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
por: Wetwittayakhlang, Panu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iv7lcvh95kgtmq5mjm46a5fi2m